SCI PHARMTECH, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.1 TWD | +0.76% |
|
+0.76% | -3.82% |
| May. 14 | SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 09 | SCI Pharmtech, Inc. Announces Board Changes | CI |
| Sales 2022 | 900M 27.77M | Sales 2023 | 1.2B 37.17M | Capitalization | 11.57B 357M |
|---|---|---|---|---|---|
| Net income 2022 | 309M 9.54M | Net income 2023 | 295M 9.11M | EV / Sales 2022 | 10.6 x |
| Net Debt 2022 | 281M 8.67M | Net Debt 2023 | 11.42M 353K | EV / Sales 2023 | 9.62 x |
| P/E ratio 2022 |
30.2
x | P/E ratio 2023 |
36
x | Employees | 239 |
| Yield 2022 |
0.26% | Yield 2023 |
1.29% | Free-Float | 56.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.76% | ||
| 1 week | +0.76% | ||
| Current month | +1.20% | ||
| 1 month | +2.42% | ||
| 3 months | +2.99% | ||
| 6 months | +1.20% | ||
| Current year | -3.82% |
1 week
92.30
93.60
1 month
90.8094.50
Current year
85.60100.50
1 year
85.60108.00
3 years
64.96119.56
5 years
54.67119.56
10 years
41.04119.56
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Chun Weng
CEO | Chief Executive Officer | - | 01-12-16 |
Wen Chen Yang
DFI | Director of Finance/CFO | - | 02-12-31 |
Wen Chih Chou
BRD | Director/Board Member | - | 10-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiang Li Chen
BRD | Director/Board Member | - | 01-12-16 |
Wei Chun Weng
CEO | Chief Executive Officer | - | 01-12-16 |
Wen Chih Chou
BRD | Director/Board Member | - | 10-08-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 93.1 | +0.76% | 199,246 |
| 24-06-06 | 92.4 | -0.54% | 307,963 |
| 24-06-05 | 92.9 | +0.43% | 260,873 |
| 24-06-04 | 92.5 | +0.11% | 148,692 |
End-of-day quote Taiwan S.E., June 06, 2024
More quotes
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
Sector
Pharmaceuticals
Calendar
2024-08-07
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -3.82% | 344M | |
| +19.01% | 80.29B | |
| +15.04% | 9.2B | |
| -18.33% | 4.67B | |
| +43.39% | 4.49B | |
| +13.95% | 4.27B | |
| +10.55% | 2.25B | |
| -28.40% | 2.13B | |
| +15.93% | 2.1B | |
| -43.17% | 1.78B |
- Stock Market
- Equities
- 4119 Stock
